W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

News

Summary of information indicated by applicants to be kept confidential in selected areas of the documentation published by AOTMiT (applicant’s analyses, verification analyses, positions of the Transparency Council, recommendations of the President) in the evaluation of reimbursement applications for the year 2021 and Q1 2022.

more...

Opinion of the Transparency Council – the active substance arsenic trioxide

more...

Opinion of the Transparency Council – Health policy programme for the prevention of meningococcal infections for children in the Municipality of Kielce

more...

Opinion of the Transparency Council – health policy programme on infertility treatment (district olkuski)

more...

Opinion of the Transparency Council – health policy programme on in vitro fertilisation (Jelenia Góra)

more...

Position of the Transparency Council – Tript-OH (oksytryptan)

more...

The Meeting of the Tariffs Council No. 22/2022 of 15.09.2022

more...

The Meeting of the Transparency Council No. 36/2022 of 12.09.2022

more...

Communication – report on tariff setting for outpatient specialist care services: bone marrow aspiration biopsy, bone marrow trepanobiopsy, external consultations

more...

Communication on the meeting of the Tariff Council on 01.09.2022

more...

Communication on the meeting of the Tariff Council on 25.08.2022

more...

The Meeting of the Tariffs Council No. 21/2022 of 25.08.2022 – update

more...

Position of the Transparency Council – Renastep

more...

Opinion of the Transparency Council – entecavirum and tenofovirum disoproxilum

more...

Opinion of the Transparency Council – health policy programme in the field of perinatal care (Municipality of Stare Babice)

more...

Recommendation of the President – on qualifying selected diagnostic, ultrasound, invasive, electrophysiological, and functional examinations as well as specialist advice and consultations for the list of guaranteed health care services in the scope of primary health care

more...

Recommendation of the President – Milupa Basic-P

more...

The Meeting of the Transparency Council No. 35/2022 of 05.09.2022

more...

The Meeting of the Tariffs Council No. 20/2022 of 25.08.2022 – update

more...

Position of the Transparency Council – Milupa Basic-P

more...

Position of the Transparency Council – Ospolot (sultiam)

more...

Position of the Transparency Council – Jardiance (empagliflozyna)

more...

Position of the Transparency Council – Yervoy (ipilimumab)

more...

Position of the Transparency Council – Opdivo (niwolumab)

more...